In vitro diagnostics (IVD) is the approach in which scientific devices and reagents are used to take a look at specimens. Such as blood, urine, stool, tissues and other frame fluids, which can be derived from the human body to detect illnesses, situations and infections? The tests can be carried out in hospitals, standalone laboratory based lab. Number of the giant technology included in vitro diagnostics include polymerase chain reaction (pcr), sequencing technology, microarray techniques and mass spectrometry, which might be used for take a look at sample instruction. Incessant improvements in IVD product design and generations have endorsed medical doctors and researchers to shift their awareness from traditional diagnostic strategies to customized drug treatments.
How Big is the Global In Vitro Diagnostics IVD Market?
The Global In Vitro Diagnostics IVD Market is expected to be around US$ 97.4 billion by 2027 and will grow at a CAGR of more than 5% in the given forecast period.
The major driving factors of Global In Vitro Diagnostics IVD Market are as follows:
• Increasing demand for technically advanced diagnostic devices
• Technical expansion to develop high sensitivity point of care hematology testing
• Improved disposable income of customers gives high expansion potential for IVD market
The restraining factors of Global In Vitro Diagnostics IVD Market are as follows:
• Strict government rules
• Inauspicious reimbursement policies
The Global In Vitro Diagnostics IVD Market is segmented on the lines of its product, technique, application, end user and regional. Based on product segmentation it covers reagents, instruments and software & services. Technique segmentation is further classified into immunodiagnostics, blood testing, molecular diagnostics, tissue diagnostics, clinical chemistry and other IVD techniques. Immunodiagnostics is classified into enzyme-linked immunosorbent assay, enzyme-linked immunospot, rapid tests, western blot and radioimmunoassay. Under molecular diagnostics segmentation it covers polymerize chain reaction, hybridization, isothermal nucleic acid technology, microarray, DNA diagnostics and others. Clinical Chemistry is segmented into basic metabolic panel, lipid profile, liver panel, electrolyte panel, thyroid function panel and specialty chemicals. Based on application segmentation it covers infectious diseases, cancer, cardiac diseases, immune system disorders, nephrological diseases, gastrointestinal diseases and other indications. Under end user segmentation it covers standalone laboratory, hospitals, academic &medical schools, point of care and others. The Global In Vitro Diagnostics IVD Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the global market for In Vitro Diagnostics IVD and related technologies.
2) Analyses of global market trends, with data from 2019, estimates for 2020 and 2021, and projections of compound annual growth rates (CAGRs) through 2027.
3) Identifications of new market opportunities and targeted promotional plans for In Vitro Diagnostics IVD.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
REPORT SCOPE:
The scope of the report includes a detailed study of global and regional markets for Global In Vitro Diagnostics IVD Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Affymetrix, Inc., AlereInc, Biomerieux, Danaher Corporation., Roche Diagnostics, Becton Dickinson and Company, Bio-Rad Laboratories, Inc., Abbott Laboratories, Bayer AG., Arkray, Inc., Sysmex Corporation, Johnson & Johnson Pvt. Ltd. And Siemens AG. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
The Global In Vitro Diagnostics IVD Market has been segmented as below:
By Product Analysis
• Reagents
• Instruments
• Software & Services
By Technique Analysis
• Immunodiagnostics
o Enzyme-Linked Immunosorbent Assay (ELISA)
o Enzyme-Linked ImmunoSpot (ELISPOT)
o Rapid Tests
o Western blot
o Radioimmunoassay (RIA)
• Blood Testing
• Molecular Diagnostics
o Polymerize Chain Reaction (PCR)
o Hybridization
o Isothermal Nucleic Acid Technology (INAAT)
o Microarray
o DNA diagnostics
o Others
• Tissue Diagnostics
• Clinical Chemistry
o Basic metabolic panel
o Lipid profile
o Liver panel
o Electrolyte panel
o Thyroid function panel
o Speciality chemicals
• Other IVD Techniques
By Application Analysis
• Infectious Diseases
• Cancer
• Cardiac Diseases
• Immune System Disorders
• Nephrological Diseases
• Gastrointestinal Diseases
• Other Indications
By End User Analysis
• Standalone Laboratory
• Hospitals
• Academic & Medical Schools
• Point of Care
• Others
By Regional Analysis
• North America
• Europe
• Asia-Pacific
• Rest of the World
Reasons to Buy this Report:
1) Obtain the most up to date information available on all Global In Vitro Diagnostics IVD Market.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of Global In Vitro Diagnostics IVD Market data.
4) Assess your competitor’s refining portfolio and its evolution.
Customization:
We can offer you custom research reports as per client’s special requirements.
Below are our New Reports :-
1 INTRODUCTION
1.1 Key Take Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Key Data Points From Primary Sources
2 Research Methodology (Page No. – 24)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Market Share Estimation
2.5 Assumptions for the Study
3 Executive Summary (Page No. – 31)
4 Premium Insights (Page No. – 40)
4.1 In Vitro Diagnostics (IVD): Market Overview
4.2 Asia-Pacific: In Vitro Diagnostics Market, By Products & Services
4.3 Geographic Snapshot of the In Vitro Diagnostics Market
4.4 Geographic Mix: In Vitro Diagnostics Market
4.5 In Vitro Diagnostics Market: Developing vs Developed Markets
5 Market Overview (Page No. – 45)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Market Drivers
5.2.1.1 Rising Incidence of Chronic Lifestyle Diseases
5.2.1.2 Increasing Adoption of Point-Of-Care Testing
5.2.1.3 Growing Awareness of Personalized Medicine
5.2.1.4 Growth in the Number of Private Diagnostic Centers
5.2.2 Market Restraints
5.2.2.1 Inadequate Reimbursement
5.2.2.2 Rising Healthcare Costs and Low Budgets
5.2.3 Market Opportunities
5.2.3.1 Introduction of A New Range of Condition-Specific Markers and Tests With Advances in Genomics and Proteomics
5.2.3.2 Emerging Economies With Increasing Investments
5.2.3.3 Growing Significance of Companion Diagnostics
5.2.4 Market Challenges
5.2.4.1 Stringent Regulatory Framework
5.2.4.2 Operational Barriers for the Use of Diagnostic Tests
6 Industry Insights (Page No. – 56)
6.1 Introduction
6.2 Industry Trends
6.2.1 Automation of Clinical Laboratory Techniques
6.2.2 Microfluidics-Based Poc and Loc Diagnostic Devices for Laboratory Testing
6.2.3 Rise in Reagent Rental Agreements
6.3 Regulatory Overview
6.3.1 North America
6.3.1.1 U.S.
6.3.1.2 Canada
6.3.2 Europe
6.3.3 Asia-Pacific
6.3.3.1 Japan
6.3.3.2 China
6.3.3.3 India
7 Global In Vitro Diagnostics Market, By Product & Service (Page No. – 65)
7.1 Introduction
7.2 Reagents & Kits
7.3 Instruments
7.4 Data Management Software
7.5 Services
8 Global In Vitro Diagnostics Market, By Technology (Page No. – 74)
8.1 Introduction
8.2 Immunochemistry/Immunoassays
8.2.1 Enzyme-Linked Immunosorbent Assay (ELISA)
8.2.1.1 Chemiluminescence Immunoassays (CLIAS)
8.2.1.2 Fluorescence Immunoassays (FIAS)
8.2.1.3 Colorimetric Immunoassays (CIS)
8.2.2 Radioimmunoassay (RIA)
8.2.3 Rapid Tests
8.2.4 Western Blot
8.2.5 Enzyme-Linked Immunospot (Elispot) Assay
8.3 Clinical Chemistry
8.3.1 Basic Metabolic Panel
8.3.2 Electrolyte Panel
8.3.3 Liver Panel
8.3.4 Lipid Profile
8.3.5 Renal Profile
8.3.6 Thyroid Function Panel
8.3.7 Specialty Chemical Tests
8.4 Molecular Diagnostics (MDX)
8.4.1 Polymerase Chain Reaction (PCR)
8.4.2 Isothermal Nucleic Acid Amplification Technology (INAAT)
8.4.3 Microarray
8.4.4 Hybridization
8.4.5 Dna Sequencing & Next-Generation Sequencing
8.4.6 Other MDX Technologies
8.5 Clinical Microbiology
8.6 Hematology
8.7 Coagulation and Hemostasis
8.8 Other IVD Technologies
9 Global In Vitro Diagnostics Market, By Application (Page No. – 114)
9.1 Introduction
9.2 Diabetes
9.3 Infectious Diseases
9.4 Oncology/Cancer
9.5 Cardiology
9.6 Nephrology
9.7 Autoimmune Diseases
9.8 Drug Testing/Pharmacogenomics
9.9 HIV/Aids
9.10 Other Applications
10 Global In Vitro Diagnostics Market, By End User (Page No. – 132)
10.1 Introduction
10.2 Hospitals
10.3 Laboratories
10.4 Point-Of-Care Testing
10.5 Patient Self-Testing
10.6 Academic Institutes
10.7 Other End Users
11 Global In Vitro Diagnostics Market, By Region (Page No. – 142)
11.1 Introduction
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 France
11.3.3 U.K.
11.3.4 Italy
11.3.5 Spain
11.3.6 Russia
11.3.7 Rest of Europe (RoE)
11.4 Asia-Pacific (APAC)
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Rest of Asia-Pacific (RoAPAC)
11.5 Latin America
11.5.1 Brazil
11.5.2 Mexico
11.5.3 Rest of Latin America (ROLA)
11.6 Middle East and Africa
12 Competitive Landscape (Page No. – 207)
12.1 Overview
12.2 Market Share Analysis
12.3 Competitive Situation and Trends
12.4 New Product Launches
12.5 Agreements, Partnerships, and Collaborations
12.6 Acquisitions
12.7 Expansions
12.8 Other Strategies
13 Company Profiles (Page No. – 215)
(Overview, Products and Services, Financials, Strategy & Development)*
13.1 Introduction
13.2 ABBott Laboratories, Inc.
13.3 Becton, Dickinson and Company
13.4 Biomérieux SA
13.5 Bio-Rad Laboratories, Inc.
13.6 Danaher Corporation
13.7 Johnson & Johnson
13.8 Roche Diagnostics
13.9 Siemens AG
13.10 Sysmex Corporation
13.11 Thermo Fisher Scientific, Inc.
13.12 Ortho-Clinical Diagnostics, Inc.
13.13 Qiagen N.V.
13.14 Diasorin S.P.A.
14 Appendix (Page No. – 275)
14.1 Insights of Industry Experts
14.2 Discussion Guide
14.3 Other Developments
14.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
14.5 Introducing RT: Real-Time Market Intelligence
14.6 Available Customizations
14.7 Related Reports
14.8 Author Details
The Global In Vitro Diagnostics IVD Market has been segmented as below:
By Product Analysis
• Reagents
• Instruments
• Software & Services
By Technique Analysis
• Immunodiagnostics
o Enzyme-Linked Immunosorbent Assay (ELISA)
o Enzyme-Linked ImmunoSpot (ELISPOT)
o Rapid Tests
o Western blot
o Radioimmunoassay (RIA)
• Blood Testing
• Molecular Diagnostics
o Polymerize Chain Reaction (PCR)
o Hybridization
o Isothermal Nucleic Acid Technology (INAAT)
o Microarray
o DNA diagnostics
o Others
• Tissue Diagnostics
• Clinical Chemistry
o Basic metabolic panel
o Lipid profile
o Liver panel
o Electrolyte panel
o Thyroid function panel
o Speciality chemicals
• Other IVD Techniques
By Application Analysis
• Infectious Diseases
• Cancer
• Cardiac Diseases
• Immune System Disorders
• Nephrological Diseases
• Gastrointestinal Diseases
• Other Indications
By End User Analysis
• Standalone Laboratory
• Hospitals
• Academic & Medical Schools
• Point of Care
• Others
By Regional Analysis
• North America
• Europe
• Asia-Pacific
• Rest of the World
SUBSCRIBE TO OUR NEWSLETTERS
